Comparison of Approaches to Determining N-Nitrosodimethylamine Impurity in Valsartan Drug Substance By GC-MS Methods
- Autores: Khorol’skii M.D.1,2, Anan’ina O.V.2, Chaplenko A.A.2, Nedkov I.V.2, Maslennikova N.V.2, Ramenskaya G.V.1
- 
							Afiliações: 
							- I. M. Sechenov First Moscow State Medical University (Sechenov University)
- Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
 
- Edição: Volume 53, Nº 8 (2019)
- Páginas: 766-770
- Seção: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245987
- DOI: https://doi.org/10.1007/s11094-019-02076-y
- ID: 245987
Citar
Resumo
Methods for determining the genotoxic impurity N-nitrosodimethylamine (NDMA) in valsartan drug substance by gas chromatography (GC) with mass-spectrometric detection in SIM and MRM modes using direct introduction and vapor-phase analysis are compared. The obtained LOQ and DL differed insignificantly. The test results led to the conclusion that use of a method corresponding to the capabilities and equipment of the laboratory was advisable.
Palavras-chave
Sobre autores
M. Khorol’skii
I. M. Sechenov First Moscow State Medical University (Sechenov University); Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
							Autor responsável pela correspondência
							Email: mkhorolski@gmail.com
				                					                																			                												                	Rússia, 							8/2 Trubetskaya St, Moscow, 119991; 8/2 Petrovskii Blvd, Moscow, 127051						
O. Anan’ina
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
														Email: mkhorolski@gmail.com
				                					                																			                												                	Rússia, 							8/2 Petrovskii Blvd, Moscow, 127051						
A. Chaplenko
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
														Email: mkhorolski@gmail.com
				                					                																			                												                	Rússia, 							8/2 Petrovskii Blvd, Moscow, 127051						
I. Nedkov
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
														Email: mkhorolski@gmail.com
				                					                																			                												                	Rússia, 							8/2 Petrovskii Blvd, Moscow, 127051						
N. Maslennikova
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
														Email: mkhorolski@gmail.com
				                					                																			                												                	Rússia, 							8/2 Petrovskii Blvd, Moscow, 127051						
G. Ramenskaya
I. M. Sechenov First Moscow State Medical University (Sechenov University)
														Email: mkhorolski@gmail.com
				                					                																			                												                	Rússia, 							8/2 Trubetskaya St, Moscow, 119991						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					